Clinical trial
Ginger Control of Chemotherapy Induced Nausea and Vomiting
NCT00065221 · National Center for Complementary and Integrative Health (NCCIH), NIH · Completed
Key facts
| NCT number | NCT00065221 |
|---|---|
| Title | Ginger Control of Chemotherapy Induced Nausea and Vomiting |
| Official title | Trial of Encapsulated Ginger as a Treatment for Chemotherapy-Induced Nausea and Vomiting |
| Lead sponsor | National Center for Complementary and Integrative Health (NCCIH), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Nausea, Vomiting, Chemotherapy |
| Intervention type | Drug |
| Interventions | Ginger |
| Enrollment | 180 |
| Start date | Jun 1, 2003 |
| Primary completion | Jan 1, 2007 |
| Completion | Jan 1, 2007 |
| First posted | Jul 22, 2003 |
| Last update posted | Jan 25, 2008 |
| Countries | Puerto Rico, United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: